U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Thursday, December 4, 2008
WHAT: To help develop an effective HIV vaccine, researchers are trying to better understand how the immune systems of a small minority of HIV-infected people known as long-term non-progressors (LTNPs) contain the virus naturally. CD8+ T cells, which kill cells infected with HIV, enable LTNPs to control HIV, but it has
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Cancer Institute (NCI) - Monday, October 20, 2008
CONTACT: NCI Office of Media Relations, 301-496-6641, e-mail: ncipressofficers@mail.nih.gov
A small antibody fragment that is highly effective in neutralizing the human immunodeficiency virus (HIV) by preventing the virus from entering cells has been identified by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). This finding may provide insight into the deve
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Sunday, September 14, 2008
CONTACT: Arthur Stone, 301-496-3583, e-mail: NIDDKMedia@mail.nih.gov
For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University.
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Wednesday, September 10, 2008
CONTACT: Robert Bock or Marianne Glass Miller, 301-496-5133, e-mail: bockr@mail.nih.gov
The drug acyclovir has long been used to suppress outbreaks of oral and genital herpes . Herpes viruses change acyclovir to a form that prevents them from reproducing. Now, it appears that after acyclovir is altered by herpes viruses, it also interferes with the AIDS virus s ability to reproduce, report researchers fro
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute on Drug Abuse (NIDA) - Friday, September 5, 2008
Stephanie Older, 301-594-6145; Main Press Office, 301-443-6245; e-mail:media@nida.nih.gov
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, today announced the first three recipients of its new Avant-Garde Award. This award is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of HIV/AIDS in drug abu
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Wednesday, August 13, 2008
Scientists at the National Institutes of Health (NIH) have found a mechanism in the immune systems of mice that can lead to the development of autoimmune disease when turned off. The findings shed light on the processes that lead to the development of autoimmunity and could also have implications for the development of
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute on Drug Abuse (NIDA) - Wednesday, August 6, 2008
CONTACT: Dorie Hightower or Stephanie Older, 301-443-6245,
Highly active antiretroviral therapy (HAART) has been extremely effective at slowing the progression of HIV infection to AIDS as well as extending the lives and improving the quality of life for those with HIV. However, some doctors have been reluctant to prescribe HAART to HIV-infected injection drug users because of
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Cancer Institute (NCI) - Wednesday, July 30, 2008
CONTACT: NCI Office of Media Relations, 301- 496-6641, e-mail: ncipressofficers@mail.nih.gov
The use of advanced imaging techniques has allowed researchers to visualize how a key part of the human immunodeficiency virus (HIV) changes shape after binding to immune system cells or to infection-fighting antibodies. Although scientists had been able to visualize individual components of this part of the virus, cal
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Wednesday, June 4, 2008
CONTACT: Robert Bock, email: bockr@mail.nih.gov or Marianne Glass Miller, email: millemag@mail.nih.gov, 301-496-5133
In many poor countries, mothers with HIV face a stark choice: to nurse their infants, and risk passing on HIV through their breast milk -- or to formula feed, and deprive their infants of much of the natural immunity needed to protect against fatal diseases of early infancy. Now, two studies supported by the National I
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Human Genome Research Institute (NHGRI) - Wednesday, April 30, 2008
A nationwide team of researchers, funded in part by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has produced the first sequence-based map of large-scale structural variation across the human genome. The work, published today in the journal Nature , provides a s
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Human Genome Research Institute (NHGRI) - Monday, April 28, 2008
CONTACT: Raymond MacDougall, 301-402-0911, e-mail: macdougallr@mail.nih.gov
A research group supported by the National Institutes of Health (NIH) has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance. In findings published today in the online edition of the Proceedings of the National Academy of Sciences,
What is a clinical trial and how does it work? What are the benefits and the risks? If you are an older adult, should you consider participating in a clinical trial? These and many other questions are addressed in Participating in Clinical Trials , a new topic just added to NIHSeniorHealth , a Web site developed by the
This information is designed to support, not replace, the relationship that exists between you and your doctor.